longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Zymeworks

ZYME

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Theravance Shareholders Approve Merger with Zymeworks Inc.

    Tip Ranks·Sep 18 at 10:02 PM
    TBPH+0.18%ZYME+0.90%
  • Theravance facing several lawsuits seeking to block Zymeworks acquisition

    businessinsider·Sep 10 at 03:15 PM
    ZYME+0.90%TBPH+0.18%
  • Theravance Biopharma announces shareholder meeting on merger deal

    PUBT·Sep 10 at 01:11 PM
    TBPH+0.18%ZYME+0.90%
  • JPMorgan Chase & Co. Boosts Zymeworks (NASDAQ:ZYME) Price Target to $33.00

    Market Beat·Sep 3 at 09:24 PM
    ZYME+0.90%
  • HC Wainwright Has Strong Estimate for Zymeworks Q3 Earnings

    Market Beat·Aug 27 at 10:12 AM
    ZYME+0.90%BLK+1.92%
  • Zymeworks (NASDAQ:ZYME) Stock Price Up 11.4% After Analyst Upgrade

    Market Beat·Aug 26 at 02:20 PM
    ZYME+0.90%JAZZ+0.30%
  • MongoDB To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday

    benzinga_article·Aug 26 at 01:26 PM
    - Wall Street financial institutions have updated their price targets and ratings for several major publicly traded corporations. - Notable adjustments include Barclays raising MongoDB Inc price target to $460 and Piper Sandler lifting Intuit Inc target to $290. - Other prominent updates involve revised forecasts from firms such as BTIG, Bernstein, and Needham regarding various market equities.
    STRK+1.14%ZYME+0.90%
  • Zymeworks (ZYME) Is Up 5.4% After New FDA Approval Triggers $250 Million Milestone Payment

    Simplywall·Aug 26 at 04:28 AM
    ZYME+0.90%JAZZ+0.30%
  • U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma | JAZZ Stock News

    StockTitan·Aug 25 at 06:00 AM
    JAZZ+0.30%
  • Deutsche Bank AG Buys Shares of 397,190 Zymeworks Inc. $ZYME

    Market Beat·Aug 24 at 07:52 AM
    ZYME+0.90%DB+0.71%